DETROIT (AP) — A Detroit-based health system is enrolling children ages 6 months to 11 years old for Moderna's COVID-19 vaccine study.
Henry Ford Health System says Thursday that the KidCOVE study will evaluate the safety and effectiveness of the pharma company's mRNA-1273 vaccine for that age group. The mRNA-1273 is the same vaccine given emergency use authorization by the FDA for people 18 and older.
Participation in the KidCOVE study will last about 14 months and require both in-person clinic visits and virtual visits. Participants will receive one injection about 28 days apart. The health system says neither the participants nor their parents will know whether they received the study vaccine or a placebo injection.
Additional Coronavirus information and resources:
Click here for a page with resources including a COVID-19 overview from the CDC, details on cases in Michigan, a timeline of Governor Gretchen Whitmer's orders since the outbreak, coronavirus' impact on Southeast Michigan, and links to more information from the Michigan Department of Health and Human Services, the CDC and the WHO.
View a global coronavirus tracker with data from Johns Hopkins University.
Find out how you can help businesses and restaurants struggling during the pandemic.
Also, get information about Rebound Mid Michigan, with stories, information, and more about coming back from COVID-19
Join the Rebound Mid Michigan Facebook Group.
See complete coverage on our Coronavirus Continuing Coverage page.